DK77880A - Fremgangsmaade til fremstilling af 2-(imidazol-1-ylmethyl) pyrroler eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af 2-(imidazol-1-ylmethyl) pyrroler eller salte deraf

Info

Publication number
DK77880A
DK77880A DK77880A DK77880A DK77880A DK 77880 A DK77880 A DK 77880A DK 77880 A DK77880 A DK 77880A DK 77880 A DK77880 A DK 77880A DK 77880 A DK77880 A DK 77880A
Authority
DK
Denmark
Prior art keywords
pyrrols
imidazol
ylmethyl
salts
preparing
Prior art date
Application number
DK77880A
Other languages
Danish (da)
English (en)
Inventor
P E Cross
R P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK77880A publication Critical patent/DK77880A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK77880A 1979-02-24 1980-02-22 Fremgangsmaade til fremstilling af 2-(imidazol-1-ylmethyl) pyrroler eller salte deraf DK77880A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7906617 1979-02-24

Publications (1)

Publication Number Publication Date
DK77880A true DK77880A (da) 1980-08-25

Family

ID=10503416

Family Applications (1)

Application Number Title Priority Date Filing Date
DK77880A DK77880A (da) 1979-02-24 1980-02-22 Fremgangsmaade til fremstilling af 2-(imidazol-1-ylmethyl) pyrroler eller salte deraf

Country Status (7)

Country Link
US (1) US4259345A (fi)
EP (1) EP0015155B1 (fi)
JP (1) JPS55120585A (fi)
DE (1) DE3062101D1 (fi)
DK (1) DK77880A (fi)
GR (1) GR73560B (fi)
IE (1) IE49273B1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (fi) * 1980-10-23 1984-07-13 Pfizer
AU559687B2 (en) * 1981-07-01 1987-03-19 Upjohn Company, The Pyridinyl-and imidazolyl-benzofurane and benzothiophenes
US4608374A (en) * 1983-11-07 1986-08-26 Hoechst-Roussel Pharmaceuticals Inc. 11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents
JPS61110266A (ja) * 1984-11-05 1986-05-28 Omron Tateisi Electronics Co カード発行方法
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
IL82401A0 (en) * 1986-05-06 1987-11-30 Merrell Dow Pharma Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them
US4737511A (en) * 1986-11-03 1988-04-12 Schering A.G. Cardiotonic imidazolylphenylpyrrol-2-ones
CH683260A5 (it) * 1991-11-29 1994-02-15 Applied Pharma Res Derivati pirrolici trisostituiti ad attività antifungina ed antibatterica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
SG44510A1 (en) * 1991-12-18 1997-12-19 Schering Corp Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
KR100381216B1 (ko) * 1997-11-28 2003-08-30 주식회사 엘지생명과학 피롤구조를갖는파네실전이효소억제제및그의제조방법
KR100388789B1 (ko) * 1998-02-02 2003-10-04 주식회사 엘지생명과학 피롤구조를갖는파네실전이효소억제제및그의제조방법
DE122010000004I1 (de) * 2000-02-15 2010-04-15 Sugen Inc Pyrrol substituierte indolin-2-on protein kinase inhibitoren
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
EP1434774A1 (en) 2001-10-10 2004-07-07 Sugen, Inc. 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115578A (en) * 1975-12-18 1978-09-19 Rohm And Haas Company 1-Substituted aralkyl imidazoles
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
EP0003901B1 (en) * 1978-02-24 1981-08-05 Pfizer Limited 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

Also Published As

Publication number Publication date
GR73560B (fi) 1984-03-15
IE49273B1 (en) 1985-09-04
US4259345A (en) 1981-03-31
JPS55120585A (en) 1980-09-17
IE800359L (en) 1980-08-24
EP0015155A1 (en) 1980-09-03
EP0015155B1 (en) 1983-02-23
DE3062101D1 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
DK331881A (da) Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte deraf
DK280083D0 (da) Fremgangsmade til fremstilling af 2-(4-puridyl)-thiazolderivater
DK28282A (da) Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf
DK466681A (da) Analogifremgangmaade til fremstilling af benzo-kondenserede heterocycliske forbindelser
DK405881A (da) Fremgangsmaade til fremstilling af 7beta-aminothiadiazolylacetylamino3-ammoniomethyl-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK221182A (da) Fremgangsmaade til fremstilling af chirale 2-(2-benzyl-3-mercaptopropionyl)amino-1-alkanolderivater eller chirale 2-(2-benzyl-3-mercaptopropionyl)amino-4-methylthiosmoersyrer eller faraaaceutisk acceptable salte af syrerne
DK483681A (da) Fremgangsmaade til fremstilling af 1-carboxy-(azaalkanoyl eller azaaralkanoyl)-indolin-2-carboxylsyrer eller salte deraf
DK294780A (da) Fremgangsmaade til fremstilling af trans-3-(4-oxo4h-quinazolin-3-yl)-2-propensyrederivater eller salte deraf
DK77880A (da) Fremgangsmaade til fremstilling af 2-(imidazol-1-ylmethyl) pyrroler eller salte deraf
ES523067A0 (es) Procedimiento para preparar 1-(2-(fenilmetilen)ciclohexil) azetidinas.
DK157009C (da) Fremgangsmaade til fremstilling af 1-(3-mercapto-2s-methylpropionyl)-pyrrolidin-2s-carboxylsyre
DK144944C (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK291979A (da) Fremgangsmaade til opberedning af aluminiumsaltslagger
DK447380A (da) Fremgangsmaade til fremstilling af d3-vitaminforbindelser
DK358183D0 (da) Fremgangsmade til fremstilling af alfa-aryl-alkansyrer eller salte deraf
DK289580A (da) Fremgangsmaade til fremstilling af heterocycliske phenoxyaminer
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK475982A (da) Fremgangsmaade til fremstilling af benzofuranoner eller salte deraf
DK495780A (da) Fremgangsmaade til fremstilling af 2-keto-l-gulonsyre eller salte deraf
DK40482A (da) Fremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolinderivater
DK506480A (da) Fremgangsmaade til fremstilling af 1-(8-quinolyl)-2-pyrrolidin eller salte deraf
DK154216C (da) Analogifremgangsmaade til fremstilling af 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl)-3-phenyl-1-propanoner eller syreadditionssalte deraf
DK211381A (da) Fremgangsmaade til fremstilling af carbapenam3-carboxylsyre- eller carbapen-2-em-3-carboxylsyre-forbindelser eller estere eller salte deraf
DK366081A (da) Fremgangsmaade til fremstilling af diaryl-imidazol-forbindelser eller salte deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment